Cited by 178Atrial Fibrillation Management and OutcomesCardiac Arrhythmias and TreatmentsCardiac pacing and defibrillation studies

Rate- and Rhythm-Control Therapies in Patients With Atrial Fibrillation: A Systematic Review

Al-Khatib, Sana M., Allen LaPointe, Nancy M., Chatterjee, Ranee, Crowley, Matthew J., Dupre, Matthew E., Kong, David F., Lopes, Renato D., Povsic, Thomas J. +5 more·2014·Annals of Internal Medicine

Abstract

BACKGROUND: The comparative effectiveness of treatments for atrial fibrillation (AF) is uncertain. PURPOSE: To evaluate the comparative effectiveness of rate- and rhythm-control therapies. DATA SOURCES: English-language studies in PubMed, EMBASE, and the Cochrane Database of Systematic Reviews between January 2000 and November 2013. STUDY SELECTION: Two reviewers independently screened citations to identify comparative studies that assessed rate- or rhythm-control therapies in patients with AF. DATA EXTRACTION: Reviewers extracted data on study design, participant characteristics, interventions, outcomes, applicability, and quality. DATA SYNTHESIS: 200 articles (162 studies) involving 28,836 patients were included. When pharmacologic rate- and rhythm-control strategies were compared, strength of evidence (SOE) was moderate supporting comparable efficacy with regard to all-cause mortality (odds ratio [OR], 1.34 [95% CI, 0.89 to 2.02]), cardiac mortality (OR, 0.96 [CI, 0.77 to 1.20]), and stroke (OR, 0.99 [CI, 0.76 to 1.30]) in older patients with mild AF symptoms. Few studies compared rate-control therapies and included outcomes of interest, which limited conclusions. For the effect of rhythm-control therapies in reducing AF recurrence, SOE was high favoring pulmonary vein isolation versus antiarrhythmic medications (OR, 5.87 [CI, 3.18 to 10.85]) and the surgical maze procedure (including pulmonary vein isolation) done during other cardiac surgery versus other cardiac surgery alone (OR, 7.94 [CI, 3.63 to 17.36]). LIMITATION: Studies were heterogeneous in interventions, populations, settings, and outcomes. CONCLUSION: Pharmacologic rate- and rhythm-control strategies have comparable efficacy across outcomes in primarily older patients with mild AF symptoms. Pulmonary vein isolation is better than antiarrhythmic medications at reducing recurrences of AF in younger patients with paroxysmal AF and mild structural heart disease. Future research should address uncertainties related to subgroups of interest and the effect of different therapies on long-term clinical outcomes. PRIMARY FUNDING SOURCE: Agency for Healthcare Research and Quality.

Integrity signals

Registry

Crossref · 10.7326/m13-1467

Cites

178 of 178 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Rhythm control and rate control may preserve cardiac function.

    “Other interventions such as rhythm control and rate control improve AF-related symptoms and may preserve cardiac function, but have not demonstrated a reduction in long-term morbidity or mortality.40,41”
  • Rhythm control and rate control have not demonstrated a reduction in long-term morbidity or mortality.

    “Other interventions such as rhythm control and rate control improve AF-related symptoms and may preserve cardiac function, but have not demonstrated a reduction in long-term morbidity or mortality.40,41”
  • Rhythm control and rate control improve AF-related symptoms.

    “Other interventions such as rhythm control and rate control improve AF-related symptoms and may preserve cardiac function, but have not demonstrated a reduction in long-term morbidity or mortality.40,41”
  • Compared with stroke prevention and rhythm control, very little robust evidence exists to inform the best type and intensity of rate control treatment, with the majority of data derived from short-term crossover trials and observational studies.

    “Compared with stroke prevention and rhythm control, very little robust evidence exists to inform the best type and intensity of rate control treatment, with the majority of data derived from short-term crossover trials and observational studies.41,[526][527][528]”
  • All trials that have compared rhythm control to rate control (with appropriate anticoagulation) therapy have resulted in neutral outcomes.

    “Although many clinicians believe that maintaining sinus rhythm can improve outcomes in AF patients, 588 all trials that have compared rhythm control to rate control (with appropriate anticoagulation) therapy have resulted in neutral outcomes.41,578,579,582,[589][590][591][592][593]”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Al-Khatib, S. M., Allen LaPointe, N. M., Chatterjee, R., Crowley, M. J., Dupre, M. E., Kong, D. F., Lopes, R. D., Povsic, T. J., Raju, S. S., Shah, B., Kosinski, A. S., McBroom, A. J., & Sanders, G. D.
Affiliations
  • From Duke Clinical Research Institute and Duke Evidence-based Practice Center, Duke University School of Medicine, and the Center for Health Services Research in Primary Care, Durham Veterans Affairs Medical Center, Durham, North Carolina.
  • Duke University (US)
Venue
Annals of Internal Medicine
Published
2014-06-03
Volume
160
Issue
11
Pages
760-773
ISSN
  • 0003-4819 (ISSN-L)
  • 1539-3704
OpenAlex
W2013946241
Cited by
178
References
178
Citations by year
2026: 8 · 2025: 11 · 2024: 12 · 2023: 11 · 2022: 10 · 2021: 25 · 2020: 17 · 2019: 18 · 2018: 19 · 2017: 15 · 2016: 17 · 2015: 10 · 2014: 5
FWCI
2.52
Type
journal article
Language
en
Open access
closed
Locations
  • Annals of Internal Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Arrhythmias and Treatments
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
Keywords
atrial fibrillation, rate control, rhythm control, pulmonary vein isolation, antiarrhythmic drugs, catheter ablation, atrial fibrillation recurrence, stroke, all-cause mortality, cardiac mortality, paroxysmal atrial fibrillation, structural heart disease, comparative effectiveness
MeSH terms
Anti-Arrhythmia Agents, Atrial Fibrillation, Electric Countershock, Heart Rate, Humans, Catheter Ablation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review